Antineoplastics

Antineoplastics Reactions 1704, p37 - 2 Jun 2018 ★ S Pleural effusion due to histoplasmosis (first report for daunorubicin): case report A 23-year-old man developed pleural effusion due to histoplasmosis during treatment with daunorubicin, cyclophosphamide, vincristine and prednisolone for mixed- phenotype acute leukaemia. The man, who was hospitalised in Post Graduate Institute of Medical Education and Research in Chandigarh, India, was diagnosed with mixed-phenotype acute leukaemia. He was started on CHOP regimen, which consisted of daunorubicin, cyclophosphamide, vincristine and prednisolone [dosages and routes not stated]. He developed breathlessness and showed worsening of existing fatigue and fever following the second week of therapy. Therefore, he was rehospitalised. His chest radiograph showed right-sided moderate pleural effusion, without any gross parenchymal abnormality. Peripheral blood smears showed 42% blasts. Cytological testing of pleural fluid and blood cultures was initiated. The man was treated with vancomycin and cefoperazone/ sulbactam. His fever did not improve; therefore, amphotericin B liposomal therapy was added [liposomal amphotericin]. Therapeutic thoracentesis showed straw-colored exudative pleural fluid with pleural fluid protein to serum protein ratio of 0.89 and protein level of 3 g/L. Cytology testing was performed on 10mL haemorrhagic pleural fluid. The smears revealed many RBCs and blasts. The blasts were http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Antineoplastics

Reactions Weekly, Volume 1704 (1) – Jun 2, 2018

Antineoplastics

Abstract

Reactions 1704, p37 - 2 Jun 2018 ★ S Pleural effusion due to histoplasmosis (first report for daunorubicin): case report A 23-year-old man developed pleural effusion due to histoplasmosis during treatment with daunorubicin, cyclophosphamide, vincristine and prednisolone for mixed- phenotype acute leukaemia. The man, who was hospitalised in Post Graduate Institute of Medical Education and Research in Chandigarh, India, was diagnosed with mixed-phenotype acute leukaemia. He was started on...
Loading next page...
 
/lp/springer_journal/antineoplastics-WxafJMc4Lk
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46680-4
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p37 - 2 Jun 2018 ★ S Pleural effusion due to histoplasmosis (first report for daunorubicin): case report A 23-year-old man developed pleural effusion due to histoplasmosis during treatment with daunorubicin, cyclophosphamide, vincristine and prednisolone for mixed- phenotype acute leukaemia. The man, who was hospitalised in Post Graduate Institute of Medical Education and Research in Chandigarh, India, was diagnosed with mixed-phenotype acute leukaemia. He was started on CHOP regimen, which consisted of daunorubicin, cyclophosphamide, vincristine and prednisolone [dosages and routes not stated]. He developed breathlessness and showed worsening of existing fatigue and fever following the second week of therapy. Therefore, he was rehospitalised. His chest radiograph showed right-sided moderate pleural effusion, without any gross parenchymal abnormality. Peripheral blood smears showed 42% blasts. Cytological testing of pleural fluid and blood cultures was initiated. The man was treated with vancomycin and cefoperazone/ sulbactam. His fever did not improve; therefore, amphotericin B liposomal therapy was added [liposomal amphotericin]. Therapeutic thoracentesis showed straw-colored exudative pleural fluid with pleural fluid protein to serum protein ratio of 0.89 and protein level of 3 g/L. Cytology testing was performed on 10mL haemorrhagic pleural fluid. The smears revealed many RBCs and blasts. The blasts were

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month